SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 170 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q1 2017. The put-call ratio across all filers is 1.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $264,000 | -52.6% | 90,922 | -27.4% | 0.03% | -57.1% |
| Q2 2017 | $557,000 | -63.3% | 125,252 | -55.0% | 0.06% | -57.4% |
| Q1 2017 | $1,518,000 | +62.5% | 278,628 | +81.7% | 0.15% | +16.5% |
| Q4 2016 | $934,000 | +641.3% | 153,376 | +569.9% | 0.13% | +647.1% |
| Q3 2016 | $126,000 | -93.0% | 22,896 | -95.2% | 0.02% | -92.9% |
| Q2 2016 | $1,804,000 | -34.6% | 474,788 | -52.5% | 0.24% | -28.5% |
| Q1 2016 | $2,760,000 | +773.4% | 1,000,000 | +1693.9% | 0.33% | +753.8% |
| Q4 2015 | $316,000 | +15.8% | 55,746 | +8.2% | 0.04% | +5.4% |
| Q3 2015 | $273,000 | -41.4% | 51,500 | -8.2% | 0.04% | -53.2% |
| Q2 2015 | $466,000 | +91.0% | 56,100 | +6.2% | 0.08% | +21.5% |
| Q1 2015 | $244,000 | – | 52,800 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 2,200,000 | $6,072,000 | 2.38% |
| GREAT POINT PARTNERS LLC | 2,175,000 | $6,003,000 | 2.15% |
| Belmont Global Advisors, Inc. | 400,000 | $1,104,000 | 1.12% |
| Trellus Management Company, LLC | 162,900 | $450,000 | 0.78% |
| PURA VIDA INVESTMENTS, LLC | 572,800 | $1,581,000 | 0.72% |
| DAFNA Capital Management LLC | 294,563 | $813,000 | 0.70% |
| Twin Securities, Inc. | 1,687,115 | $4,656,000 | 0.58% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 1,000,000 | $2,760,000 | 0.33% |
| WALL STREET ASSOCIATES | 269,300 | $743,000 | 0.31% |
| Paulson & Co. | 11,090,000 | $30,608,000 | 0.23% |